Intrexon | XON - Кредиторская задолженность





Кредиторская задолженность Изменить Дата
Agenus USD 71.08M 11.9M 2026-03
Alaunos Therapeutics USD 400K 213K 2026-03
Amgen USD 19.52B 1.37B 2026-03
Anika Therapeutics USD 6.34M 298K 2026-03
Arrowhead Research USD 30.75M 2.19M 2026-03
AstraZeneca USD 22.51B 2.78B 2026-03
Bristol-Myers Squibb USD 4.23B 659M 2026-03
Gilead Sciences USD 645M 70M 2026-03
GlaxoSmithKline GBP 14.34B 1.05B 2026-03
Heron Therapeutics USD 8.97M 24K 2026-03
Incyte USD 228.62M 1.41B 2026-03
Intrexon USD 4.85M 3.12M 2024-06
Karyopharm Therapeutics USD 4M 1.39M 2025-12
Ligand Pharmaceuticals USD 37.11M 33.87M 2026-03
MacroGenics USD 4.29M 500K 2026-03
MannKind USD 16.14M 7.11M 2026-03
Merck USD 3.86B 541M 2026-03
Novartis USD 4.32B 134M 2026-03
Rigel Pharmaceuticals USD 3.85M 3.44M 2025-09
Roche Holding CHF 5.78B 1.27B 2025-12
Sangamo BioSciences USD 10.74M 7.46M 2025-06
Thermo Fisher Scientific USD 3.34B 278M 2026-03
Veracyte USD 6.91M 2.32M 2026-03
Xencor USD 7.92M 2.91M 2026-03